Acne treatment: research progress and new perspectives von Li, Yuwei, Hu, Xinhong, Dong, Gaohong, Wang, Xiaoxia, Liu, Tao

Volltext

Cardiac Allograft Vasculopathy by Intravascular Ultrasound in Heart Transplant Patients von Kobashigawa, Jon A., MD, Pauly, Daniel F., MD, PhD, Starling, Randall C., MD, MPH, Eisen, Howard, MD, Ross, Heather, MD, Wang, Shoei-Shen, MD, Cantin, Bernard, MD, PhD, Hill, James A., MD, MS, Lopez, Patricia, MD, Dong, Gaohong, PhD, Nicholls, Stephen J., MBBS, PhD

Volltext

Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation von Langer, Robert M, Hené, Ronald, Vitko, Stefan, Christiaans, Maarten, Tedesco-Silva Jr, Helio, Ciechanowski, Kazimierz, Cassuto, Elisabeth, Rostaing, Lionel, Vilatoba, Mario, Machein, Uwe, Ulbricht, Bettina, Junge, Guido, Dong, Gaohong, Pascual, Julio

Volltext

A varying-stage adaptive phase II/III clinical trial design von Dong, Gaohong

Volltext

The stratified win ratio von Dong, Gaohong, Qiu, Junshan, Wang, Duolao, Vandemeulebroecke, Marc

Volltext

Impact of De Novo Everolimus-Based Immunosuppression on Incisional Complications in Heart Transplantation von ZUCKERMANN, Andreas, ARIZON, Jose M, DONG, Gaohong, EISEN, Howard J, KOBASHIGAWA, Jon, LEHMKUHL, Hans, ROSS, Heather, PELLIGRINI, Carlo, WANG, Shoei-Shen, BARTEN, Markus J

Volltext

A modified varying-stage adaptive phase II/III clinical trial design von Dong, Gaohong, Vandemeulebroecke, Marc

Volltext

A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components von Dong, Gaohong, Li, Di, Ballerstedt, Steffen, Vandemeulebroecke, Marc

Volltext

Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study von Fischer, Lutz, Saliba, Faouzi, Kaiser, Gernot M, De Carlis, Luciano, Metselaar, Herold J, De Simone, Paolo, Duvoux, Christophe, Nevens, Frederik, Fung, John J, Dong, Gaohong, Rauer, Barbara, Junge, Guido

Volltext

Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trials von Cui, Ying, Dong, Gaohong, Kuan, Pei Fen, Huang, Bo

Volltext

Adjusting win statistics for dependent censoring von Dong, Gaohong, Huang, Bo, Wang, Duolao, Verbeeck, Johan, Wang, Jiuzhou, Hoaglin, David C.

Volltext

The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring von Dong, Gaohong, Mao, Lu, Huang, Bo, Gamalo-Siebers, Margaret, Wang, Jiuzhou, Yu, GuangLei, Hoaglin, David C.

Volltext

Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes von Dong, Gaohong, Huang, Bo, Verbeeck, Johan, Cui, Ying, Song, James, Gamalo‐Siebers, Margaret, Wang, Duolao, Hoaglin, David C., Seifu, Yodit, Mütze, Tobias, Kolassa, John

Volltext

The win odds: statistical inference and regression von Song, James, Verbeeck, Johan, Huang, Bo, Hoaglin, David C., Gamalo-Siebers, Margaret, Seifu, Yodit, Wang, Duolao, Cooner, Freda, Dong, Gaohong

Volltext

The stratified win statistics (win ratio, win odds, and net benefit) von Dong, Gaohong, Hoaglin, David C., Huang, Bo, Cui, Ying, Wang, Duolao, Cheng, Yu, Gamalo‐Siebers, Margaret

Volltext

The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards von Dong, Gaohong, Huang, Bo, Chang, Yu‐Wei, Seifu, Yodit, Song, James, Hoaglin, David C.

Volltext

High expression of DNMT3B promotes proliferation and invasion of hepatocellular carcinoma cells via Hippo signaling pathway von Dong, Gaohong, Qiu, Fuliang, Liu, Changan, Wu, Hao, Liu, Yan

Volltext

The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of right censoring von Dong, Gaohong, Mao, Lu, Huang, Bo, Gamalo-Siebers, Margaret, Wang, Jiuzhou, Yu, GuangLei, Hoaglin, David C.

Volltext

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial von Zuckermann, Andreas, Wang, Shoei-Shen, Ross, Heather, Frigerio, Maria, Eisen, Howard J., Bara, Christoph, Hoefer, Daniel, Cotrufo, Maurizio, Dong, Gaohong, Junge, Guido, Keogh, Anne M.

Volltext

Do patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus? von De Simone, Paolo, Saliba, Faouzi, Dong, Gaohong, Escrig, Cesar, Fischer, Lutz

Volltext